Abu Dhabi restaurant closed over food safety violations
The Abu Dhabi Agriculture and Food Safety Authority (Adafsa) announced on Friday that Al Rabia Restaurant, in Gayathi – Al Dhafra Region – has been administratively closed due to food safety violations.
A post on X states that practices in the restaurant pose a 'serious risk to public health'.
It follows the closing down of five restaurants and one supermarket in the emirate last month.
Lahore Garden Grill Restaurant & Cafeteria in Al Khalidiya; Karak Future Cafeteria in Abu Dhabi Island; and Al Maqam Corner Restaurant, Pak Ravi Restaurant (branch 1) and Salty Desi Darbar Restaurant, all in Musaffah Industrial Area, were closed, as was the Rich & Fresh Supermarket in Mohammed Bin Zayed City.
All food outlets undergo regular inspections to ensure high food safety standards, Adafsa said. The authority also urged the public to report any violations, including suspected food contamination or non-compliance, by calling the Abu Dhabi Government's freephone number on 800 555.
Driving up standards
The authority carries out tens of thousands of inspections each year in an effort to protect the health of the public and take enforcement action against restaurants that break the rules.
The National spent a day with food inspectors last year to take a closer look at how they work to raise food health standards.
The authority said outlets with confirmed cases of food poisoning are shut with immediate effect and cannot reopen until they pass an inspection.
Establishments where customers previously suffered food poisoning and outlets that had complaints made against them through official channels are most likely to be under enhanced scrutiny, as is any business that was given a low grade in previous inspections.
Assessments are conducted at restaurants, cafes, cloud kitchens and schools, as well as businesses that recently received a licence to operate. Inspections happen without notice and can vary in frequency.
Watch: A day with Abu Dhabi's food inspectors
Hashtags
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
Zawya
9 hours ago
- Zawya
Eritrea: National Conference on Food Safety and Agricultural Products
The Ministry of Agriculture organized a national conference on 3 July in Asmara under the theme 'Ensuring Food Safety is the Responsibility of All.' The objective of the conference was to enhance the understanding of food safety among farmers and food processing enterprises. Speaking at the event, Mr. Tekleab Misgina, Director General of Regulatory Services at the Ministry of Agriculture, emphasized the critical link between food and life. He noted that ensuring safety and cleanliness throughout the entire food production chain—from farm to consumer—is a collective responsibility. During the conference, briefings were delivered on several topics, including the significance of animal fodder, the safe use of pesticides and animal medicines, food quality capacity, and its management, among other relevant issues. Participants held extensive discussions on the topics raised and adopted various recommendations, including the preparation of reference materials based on periodic seminars, increased attention to indigenous plants, and other action points. The workshop was attended by representatives of farmers from across the country, food processing enterprises, exemplary farmers, agricultural experts, and invited guests. Distributed by APO Group on behalf of Ministry of Information, Eritrea.
Al Etihad
10 hours ago
- Al Etihad
Abu Dhabi to partner with GEMMABio Therapeutics, advance gene therapies for children with spinal muscular atrophy
5 July 2025 19:52 ABU DHABI (WAM)The Department of Health – Abu Dhabi (DoH), the regulator of the healthcare sector in the Emirate, has announced its plans to partner with GEMMABio Therapeutics (GEMMABio), a pioneering global biotechnology company dedicated to advancing global access to gene therapies for rare diseases, in collaboration with M42, a global health champion powered by AI, technology and genomics, and PureHealth, the largest healthcare group in the Middle East. The announcement follows a high-level meeting, during the BIO International Convention 2025 in Boston, between senior leaders from GEMMABio and key stakeholders from Abu Dhabi's health and life sciences ecosystem. Through this strategic partnership, the entities will jointly establish dedicated manufacturing and research centres within Abu Dhabi's academic health institutions, enabling patients from across the MENA region to access cutting-edge clinical trials and, eventually, approved gene collaboration will kick off with a clinical trial evaluating a next-generation gene therapy product in children with spinal muscular atrophy type 1 (SMA1), setting a precedent for expanding access to life-saving therapies Mohamed Alameri, Acting Director of Genome and Biobank Division at the Department of Health – Abu Dhabi, said, 'Our partnership with GEMMABio marks a pivotal step in Abu Dhabi's journey to become a global leader in developing gene therapies for rare diseases leveraging the Emirati Genome Programme. At DoH, we are committed to reshaping innovation, early detection and personalised care by strengthening the Emirate's capacity to develop, test and scale innovative therapeutics. Through these efforts, we are advancing life sciences applications while offering real hope to patients and families across the region and beyond.'The collaboration will unite the shared vision and technology to further strengthen Abu Dhabi's gene therapy R&D ecosystem, and see the emirate serving as a regional hub for GEMMABio's translational and clinical research activities.A best-in-class gene therapy contract development and research manufacturing organisation will be established in Abu Dhabi as a joint venture between M42 and GEMMABio. Additionally, regional access to GEMMABio's commercialised gene products will be coordinated through Abu Dhabi's gene therapy research and treatment by the emirate's state-of-the-art infrastructure, forward-looking policies and the Health, Endurance, Longevity and Medicine (HELM) Life Sciences Cluster, Abu Dhabi is offering streamlined licensing and co-commercialisation processes, alongside co-investment schemes and tax relief for biotech startups. Together, these enablers position Abu Dhabi as a leading global hub for life sciences Jim Wilson, Founder, President, and CEO of GEMMABio, said, 'This is a transformational partnership—one that will play a pivotal role in unlocking global access to life-saving treatments for patients with rare diseases. The stakeholders in Abu Dhabi are building a globally recognised gene therapy ecosystem whose impact on the future of life sciences will be both profound and far-reaching. Together, we are aligning scientific innovation with bold ambition to accelerate progress where it's needed most.'Dimitris Moulavasilis, Group Chief Executive Officer of M42, said, 'This partnership helps Abu Dhabi usher in another frontier in the future of health. With our integrated AI- and data-led ecosystem and advancements in precision, prevention, and prediction, this collaboration extends the impact of the Emirati Genome Programme into gene therapeutics targeting rare diseases."M42 is focused on developing genomic insights, fighting against rare diseases and saving lives. Our partnership with the Department of Health – Abu Dhabi and GEMMABio will accelerate this effort, ensuring people in the UAE and beyond get the gene therapies they need for longer, healthier lives.'This strategic partnership reinforces Abu Dhabi's recent strides in rare disease gene therapies and precision medicine. The emirate has significantly expanded its genomics capabilities through the Emirati Genome Programme, with over 800,000 genome samples sequenced, marking one of the world's most advanced national genomic Dhabi continues to pioneer the administration of cutting-edge gene therapies, expanding access to life-saving treatments that were previously unavailable in the region. With sustained investment in research, talent, and infrastructure, the emirate is reinforcing its position as a regional leader in life sciences and medical Saif Al Qubaisi, Group Chief Operating Officer of PureHealth, said, 'This collaboration is a powerful reflection of Abu Dhabi's growing influence as a global centre for health innovation. By joining forces with GEMMABio and our strategic partners, we are not only expanding access to advanced gene therapies, but also reinforcing the Emirate's long-term commitment to solving some of the world's most complex health challenges. PureHealth is proud to contribute through its integrated research capabilities and commitment to clinical excellence, aligned with the Department of Health's vision to deliver life-changing outcomes for patients across the region and beyond.'Led by DoH, a high-level delegation embarked on a strategic mission to the US from June 15 to 21, 2025. This visit focused on knowledge exchange, investment opportunities, and the signing of new agreements aimed at accelerating the adoption of advanced health solutions. Representing Abu Dhabi's innovation ecosystem, the delegation included key stakeholders such as the Abu Dhabi Investment Office, Mubadala BIO, M42, Masdar City, KEZAD, PureHealth, and Etihad Cargo, New York University Abu Dhabi (NYUAD), Khalifa University, and Mohamed bin Zayed University of Artificial Intelligence (MBZUAI), and startAD.
Zawya
16 hours ago
- Zawya
United States (U.S.) Government Supports Regional Emergency Management Strengthening
Today the first cohort of the Regional Public Health Emergency Management Training graduated in Abuja. The intermediate level training was hosted by the United States Centers for Disease Control and Prevention (U.S. CDC) in collaboration with the Nigeria Centre for Disease Control and Prevention. Seventeen public health emergency operations center staff members from countries across the region (Nigeria, Benin, Ghana, Sierra Leone, The Gambia, Liberia, and Mali) participated in the two-week training. They learned and strengthened the skills needed to effectively operate incident management systems for outbreak preparedness and response. As a result, the region is now better equipped to prepare for and respond to epidemics and pandemics. In her remarks at the graduation ceremony, the U.S. CDC Division of Global Health Protection Acting Program Director Asmau Aminu-Alhaji thanked the graduates for their dedication to public health both at home and across the region and highlighted the importance of public health collaboration and communication across borders. The Public Health Emergency Management Professional Certification Program is part of the U.S. Government's support for global health Security in Nigeria and globally. It provides emergency operations staff and other public health experts with specialized training in public health emergency management, operations, and other critical preparedness and response skills. Distributed by APO Group on behalf of U.S. Embassy and Consulate in Nigeria.
